Introduction
============

The neurohormone N-terminal pro-B-type natriuretic peptide (NT-proBNP) is predominantly released from the left ventricle in response to increasing wall tension, and is suggested as a useful screening test for suspected left ventricular systolic dysfunction (LVSD).

Aim
===

To evaluate the predictive value of different NT-proBNP reference cut-off values in patients with clinical symptoms and signs suggestive of LVSD.

Methods
=======

NT-proBNP was measured in 1054 patients with clinical symptoms and signs suggestive of LVSD over a 1-year period (September 2003--October 2004). We retrospectively reviewed our digital archive echocardiographic database.

Results
=======

An echocardiogram was performed in 549/1054 (52%) patients. NT-proBNP was \>150 ng/l in 744/1054 patients (71%), 42% male, median age 76 years (33--100 years) and \> 500 ng/l in 411/1054 patients (40%), 50% male, median age 76 years (33--100 years). ROC curves are shown for NT-proBNP cut-off values of 150 ng/l, positive predictive value (PPV) 0.22 (confidence interval \[CI\] 0.19--0.25), negative predictive value (NPV) 0.97 (CI 0.94--0.98), and 500 ng/l, PPV 0.3 (CI 0.26--0.35), NPV 0.93 (CI 0.9--0.94), for the detection of LVSD.

At a cut-off value of 500 ng/l, NT-proBNP has a sensitivity 0.85 (CI 0.76--0.91), specificity 0.67 (CI 0.64--0.69), PPV 0.18 (CI 0.15--0.22), and NPV 0.98 (CI 0.97--0.99) at detecting moderate to severe LV impairment.

Conclusion
==========

NT-proBNP is a useful tool in the \'rule-out\' of LVSD. An NT-proBNP level of 500 ng/l has a similar negative predictive value to an NT-proBNP level of 150 ng/l with improved positive predictive value. This is particularly important in this population where other confounding comorbidities are common.
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